Key Takeaways
- • Bill Ackman's Pershing Square Foundation commits $260 million to acquire two Upper West Side Manhattan buildings and establish the Ackman Oxman Institute, a comprehensive brain research and treatment facility in partnership with Mount Sinai.
- • The project encompasses 400,000 square feet at 125 West End Avenue ($190 million purchase) and an adjoining building at 320 West 66th Street ($70 million), with potential expansion to nearly 700,000 square feet through additional development rights.
- • The initiative was catalyzed by a personal medical crisis: Ackman's 26-year-old daughter Lucy suffered a severe brain hemorrhage in February 2026, survived after 15 hours without medical intervention at Mount Sinai, but sustained permanent neurological damage including loss of voice and most of her sight.
- • The institute will focus on comprehensive brain research and treatment spanning rehabilitation, longevity studies, nutrition, and clinical applications—positioning it as a major life sciences asset in Manhattan's emerging biotech corridor.
- • The facility will be housed in the existing West End Labs campus, which will be rebranded as the Ackman Oxman Institute, combining Ackman's name with that of his wife Neri Oxman.
Summary
Billionaire hedge fund manager Bill Ackman has announced a $260 million philanthropic investment through his Pershing Square Foundation to establish a major brain research and treatment institute on Manhattan's Upper West Side. The project was directly inspired by a traumatic family event: in February 2026, Ackman's 26-year-old daughter Lucy suffered a severe brain hemorrhage and was discovered on the floor of her apartment approximately 15 hours after the initial event. According to Ackman's own account, such an extended period of brain pressure would ordinarily be fatal, making her survival medically unusual. While Lucy survived the acute injury at Mount Sinai, she sustained significant neurological consequences, including loss of voice and most of her sight, though Ackman reports she is improving substantially.
The capital deployment includes two separate real estate acquisitions on Manhattan's Upper West Side. Ackman's foundation purchased 125 West End Avenue, a 400,000-square-foot building currently operating as West End Labs, for $190 million. The foundation simultaneously signed a contract to acquire an adjoining property at 320 West 66th Street for $70 million. Combined with additional development rights, the complete facility will ultimately span approximately 700,000 square feet, positioning it as a substantial life sciences campus in Manhattan.
The new facility will be renamed the Ackman Oxman Institute, incorporating both Ackman's name and that of his wife Neri Oxman. The institute will operate in partnership with Mount Sinai and will conduct comprehensive brain research and clinical treatment across multiple domains, including rehabilitation protocols, longevity research, nutritional science, and clinical applications. This represents a significant institutional commitment to neuroscience research infrastructure in New York City and reflects the family office's expansion into life sciences philanthropy alongside Ackman's primary hedge fund operations at Pershing Square Capital Management.
The capital deployment includes two separate real estate acquisitions on Manhattan's Upper West Side. Ackman's foundation purchased 125 West End Avenue, a 400,000-square-foot building currently operating as West End Labs, for $190 million. The foundation simultaneously signed a contract to acquire an adjoining property at 320 West 66th Street for $70 million. Combined with additional development rights, the complete facility will ultimately span approximately 700,000 square feet, positioning it as a substantial life sciences campus in Manhattan.
The new facility will be renamed the Ackman Oxman Institute, incorporating both Ackman's name and that of his wife Neri Oxman. The institute will operate in partnership with Mount Sinai and will conduct comprehensive brain research and clinical treatment across multiple domains, including rehabilitation protocols, longevity research, nutritional science, and clinical applications. This represents a significant institutional commitment to neuroscience research infrastructure in New York City and reflects the family office's expansion into life sciences philanthropy alongside Ackman's primary hedge fund operations at Pershing Square Capital Management.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.